Cardiovascular
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide. At Boehringer Ingelheim we address unmet medical need by providing innovative treatments that improve the care of patients suffering from a range of cardiovascular conditions including irregular heart beats (atrial fibrillation), stroke, blood clots in deep veins or lungs (deep vein thrombosis or pulmonary embolism), high blood pressure (hypertension) or heart attack (myocardial infarction).
Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right.
-
Stroke, don’t stay at home!
COVID-19
Learn why the Angels Initiative is urging anyone who experiences stroke symptoms to seek immediate medical care, even during the pandemic
-
Myocardial Infarction
Learn more about the latest guidelines, watch recent webcasts or explore training slide kits
-
Acute Ischaemic Stroke
Learn more about the latest guidelines, watch recent webcasts or explore training slide kits
-
Cardiovascular
Learn more about the Turning The Tide documentary series on non-communicable diseases
-
Cardiovascular
Learn how the Angels Initiative helps to build more and better stroke-ready hospitals
-
Stroke Prevention
Telling My Story is a video series featuring stories from across the world from patients with atrial fibrillation (AF), deep vein thrombosis (DVT) and pulmonary embolism (PE).
-
-
Innovation and Healthcare
Find out more about our new pilot stroke rehabilitation Consanas.
-
AF Patient Preferences Survey - Introduction
Stroke Prevention
Introduction, objectives and overview of the patient population in the AF Patient Preferences Survey